Oleksowicz L - Search Results

1

Concurrent phase I trials of intravenous interleukin 6 in solid tumor patients: reversible dose-limiting neurological toxicity.

Sosman JA, Aronson FR, Sznol M, Atkins MB, Dutcher JP, Weiss GR, Isaacs RE, Margolin KA, Fisher RI, Ernest ML, Mier J, Oleksowicz L, Eckhardt JR, Levitt D, Doroshow JH. Sosman JA, et al. Among authors: oleksowicz l. Clin Cancer Res. 1997 Jan;3(1):39-46. Clin Cancer Res. 1997. PMID: 9815535 Clinical Trial.

2

The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma.

McDermott DF, Cheng SC, Signoretti S, Margolin KA, Clark JI, Sosman JA, Dutcher JP, Logan TF, Curti BD, Ernstoff MS, Appleman L, Wong MK, Khushalani NI, Oleksowicz L, Vaishampayan UN, Mier JW, Panka DJ, Bhatt RS, Bailey AS, Leibovich BC, Kwon ED, Kabbinavar FF, Belldegrun AS, Figlin RA, Pantuck AJ, Regan MM, Atkins MB. McDermott DF, et al. Among authors: oleksowicz l. Clin Cancer Res. 2015 Feb 1;21(3):561-8. doi: 10.1158/1078-0432.CCR-14-1520. Epub 2014 Nov 25. Clin Cancer Res. 2015. PMID: 25424850 Free PMC article. Clinical Trial.

3

A phase II trial of dose-intensive interleukin-2 in metastatic renal cell carcinoma.

Oleksowicz L, Dutcher JP. Oleksowicz L, et al. J Cancer Res Clin Oncol. 1999;125(2):101-8. doi: 10.1007/s004320050249. J Cancer Res Clin Oncol. 1999. PMID: 10190317 Clinical Trial.

4

A phase II study of the continuous intravenous infusion of interleukin-6 for metastatic renal cell carcinoma.

Weiss GR, Margolin KA, Sznol M, Atkins MB, Oleksowicz L, Isaacs R, Sosman JA, Doroshow JH, Trehu EG, Dutcher JP, et al. Weiss GR, et al. Among authors: oleksowicz l. J Immunother Emphasis Tumor Immunol. 1995 Jul;18(1):52-6. doi: 10.1097/00002371-199507000-00007. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8535571 Clinical Trial. No abstract available.

5

Alterations in platelet function in patients receiving interleukin-6 as cytokine therapy.

Oleksowicz L, Puszkin E, Mrowiec Z, Isaacs R, Dutcher JP. Oleksowicz L, et al. Cancer Invest. 1996;14(4):307-16. doi: 10.3109/07357909609012156. Cancer Invest. 1996. PMID: 8689424 Clinical Trial.

6

Successful treatment of a patient on adrenal steroid replacement therapy with high-dose bolus interleukin-2 for metastatic renal cell carcinoma.

Deshpande H, Dutcher JP, Novik Y, Oleksowicz L. Deshpande H, et al. Among authors: oleksowicz l. Cancer J Sci Am. 1999 Jan-Feb;5(1):52-3. Cancer J Sci Am. 1999. PMID: 10188062 No abstract available.

7

Effects of interleukin-2 administration on platelet function in cancer patients.

Oleksowicz L, Zuckerman D, Mrowiec Z, Puszkin E, Dutcher JP. Oleksowicz L, et al. Am J Hematol. 1994 Mar;45(3):224-31. doi: 10.1002/ajh.2830450306. Am J Hematol. 1994. PMID: 8296793

8

Acquired Glanzmann's thrombasthenia associated with Hodgkin's lymphoma: a case report and review of the literature.

Malik U, Dutcher JP, Oleksowicz L. Malik U, et al. Among authors: oleksowicz l. Cancer. 1998 May 1;82(9):1764-8. doi: 10.1002/(sici)1097-0142(19980501)82:9<1769::aid-cncr25>3.0.co;2-1. Cancer. 1998. PMID: 9576300 Review.

9

A Review of the New Cytokines: IL-4, IL-6, IL-11, and IL-12.

Oleksowicz L, Dutcher JP. Oleksowicz L, et al. Am J Ther. 1994 Aug;1(2):107-115. doi: 10.1097/00045391-199408000-00002. Am J Ther. 1994. PMID: 11835074

10

Leukocytoclastic vasculitis associated with nizatidine therapy.

Suh JG, Oleksowicz L, Dutcher JP. Suh JG, et al. Among authors: oleksowicz l. Am J Med. 1997 Feb;102(2):216-7. doi: 10.1016/s0002-9343(96)00356-7. Am J Med. 1997. PMID: 9217573 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters